Defibrotide sodium

Defibrotide sodium

 

Severe Veno-Occlusive Disease (VOD) Treatment

Molecular Name: Defibrotide sodium

Active Ingredient: Defibrotide sodium
Strength: 80 mg/mL

List of Excipients: Sodium hydroxide (for pH adjustment), hydrochloric acid (for pH adjustment), water for injection.

website background
Doctor

Why is Kineret injection prescribed?

The prescription medicine KINERET (anakinra), commonly known as an interleukin-1 receptor antagonist (IL-1Ra), is only available to adults over the age of 18 to:

To administer Kineret, a subcutaneous injection is used.

Kineret is provided in a graduated prefilled syringe and is ready for use. Using the graduated prefilled syringe, doses between 20 and 100 mg are possible. The syringe is inappropriate for pediatric patients with a body weight below 10 kg because the minimum dose is 20 mg.

Who should not take KINERET?

If you’re unsure, speak with your doctor.

What are the possible side effects of KINERET?

Severe possible side effects of KINERET include:

What documents are required to import KINERET to Dubai?

Individual Patients or hospitals may import Kineret 100 mg at a reasonable price
The following paperwork is necessary to import:

Special Precautions For Kineret

Defibrotide sodium is an anticoagulant medication used to treat severe veno-occlusive disease (VOD) in people who have undergone hematopoietic stem-cell transplantation (HSCT). VOD is a rare and potentially life-threatening complication that can occur after HSCT. Defibrotide sodium works by reducing blood clotting and improving blood flow in the liver. It is administered through intravenous injection.

Special Storage Precautions: Store below 25°C. Do not freeze. Protect from light.

Key Features:

  • Defibrotide sodium is an anticoagulant medication used to treat severe veno-occlusive disease (VOD) in people who have undergone hematopoietic stem-cell transplantation (HSCT).
  • VOD is a rare and potentially life-threatening complication that can occur after HSCT.
  • Defibrotide sodium works by reducing blood clotting and improving blood flow in the liver.
  • It is administered through intravenous injection.
0 +

Distributors

0 +

Ware House

0 +

Awards

FAQ's

  • You should not use Defibrotide sodium if you are allergic to it.
  • You should not use defibrotide if you have active bleeding or a history of bleeding in the brain.
  • Store below 25°C. Do not freeze. Protect from light.
  • Defibrotide sodium is effective in treating severe veno-occlusive disease (VOD) in people who have undergone hematopoietic stem-cell transplantation (HSCT).
  • Defibrotide sodium is administered through intravenous injection.
  • The recommended dosage for adults and children weighing more than 40 kg is 6.25 mg/kg every 6 hours for at least 21 days.
  • Common side effects may include bleeding, low blood pressure, nausea, vomiting, diarrhea, headache, fever, or chills.
  • Serious side effects may include bleeding in the brain or other parts of the body.